Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
Zoster Live (Zostavax) in 2023
8,908 adverse event reports (-7% vs 2022)
2023 Reporting Summary
In 2023, 8,908 adverse event reports were filed for Zoster Live (Zostavax) in VAERS. This represents 6.3% of all 140,312 reports for this vaccine.
Of these reports, 26 mentioned death, 211 involved hospitalization, 460 required ER visits, and 91 reported disability.
Compared to the average of 6,673 reports per year for this vaccine, 2023 was above average (+33%).
💡 What This Means
In 2023, reporting for Zoster Live (Zostavax) was within typical ranges. As always, VAERS data reflects reports filed, not confirmed adverse events. Trends should be interpreted alongside vaccination volume and population health data.
All Years for Zoster Live (Zostavax)
Understanding Yearly Data
Quick Facts
Related Pages
Data Source
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.